MARKET

ANGO

ANGO

AngioDynamics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

23.14
+0.01
+0.04%
Closed 16:00 05/11 EDT
OPEN
22.75
PREV CLOSE
23.13
HIGH
23.45
LOW
22.55
VOLUME
160.58K
TURNOVER
--
52 WEEK HIGH
25.25
52 WEEK LOW
8.05
MARKET CAP
882.50M
P/E (TTM)
-5.2104
1D
5D
1M
3M
1Y
5Y
AngioDynamics (ANGO) Up 4.3% Since Last Earnings Report: Can It Continue?
AngioDynamics (ANGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks · 04/29 16:30
Centesis Catheter Market 2021 Analysis by Expert - Medtronic, BD, B. Braun, AngioDynamics, Boston Scientific Corporation, ARGON MEDICAL, Avanos Medical Devices, Axiom Medical, Blue Neem Medical Devices
Market Insight Reports · 04/26 11:49
Why You Should Hold AngioDynamics (ANGO) in Your Portfolio
Investor optimism is high on AngioDynamics (ANGO) stock, courtesy of its solid prospects.
Zacks · 04/20 17:05
Insider Trends: AngioDynamics Insider Exercises Option/Derivative Security to Acquire Stock Sells Portion to Pay Tax, Buy Trend Intact
MT Newswires · 04/16 17:44
PAVmed Chairman & CEO Lishan Aklog, M.D. named Top 50 Healthcare Technology CEO by Healthcare Technology Report
NEW YORK, April 15, Apr 15, 2021 (GLOBE NEWSWIRE via COMTEX) -- NEW YORK, April 15, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the "Company"...
GlobeNewswire · 04/15 13:30
AngioDynamics (ANGO) Receives a Buy from Raymond James
In a report released today, Jayson Bedford from Raymond James maintained a Buy rating on AngioDynamics (ANGO). The company's shares closed last Monday at
SmarterAnalyst · 04/12 20:36
AngioDynamics Submits 510(K) Application For AlphaVac System
Minimally invasive medical devices provider AngioDynamic Inc has submitted a 510(K) application for its AlphaVac System to the U.S. Food and Drug Administration (FDA). The Alphavac System is an off-circuit, multi-purpose mechanical aspiration thrombectomy ...
SmarterAnalyst · 04/12 12:27
DJ AngioDynamics Seeks FDA Clearance for Mechanical Thrombectomy System
Dow Jones · 04/12 10:13
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ANGO. Analyze the recent business situations of AngioDynamics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ANGO stock price target is 25.50 with a high estimate of 27.00 and a low estimate of 24.00.
EPS
Institutional Holdings
Institutions: 258
Institutional Holdings: 38.56M
% Owned: 101.10%
Shares Outstanding: 38.14M
TypeInstitutionsShares
Increased
39
1.92M
New
22
1.20M
Decreased
59
2.49M
Sold Out
13
954.24K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.71%
Healthcare Equipment & Supplies
-0.50%
Key Executives
Chairman/Independent Director
Howard Donnelly
President/Chief Executive Officer/Director
James Clemmer
Chief Financial Officer/Executive Vice President/IR Contact Officer
Stephen Trowbridge
Senior Vice President/General Counsel/Secretary
Richard Rosenzweig
Senior Vice President/General Manager
Brent Boucher
Senior Vice President/General Manager
Chad Campbell
Senior Vice President/General Manager
Scott Centea
Senior Vice President/Director of Human Resources
Marna Bronfen-Moore
Senior Vice President
Benjamin Davis
Senior Vice President
David Helsel
Senior Vice President
Warren Nighan
Senior Vice President
Kim Seabury
Other
Juan Serna
Independent Director
Eileen Auen
Independent Director
Wesley Johnson
Independent Director
Karen Licitra
Independent Director
Dennis Meteny
Independent Director
Jan Reed
Independent Director
Michael Tarnoff
No Data
  • All
  • Financials
  • Insiders
More
About ANGO
AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Vascular Interventions & Therapies, Vascular Access and Oncology. The Company's Vascular Interventions & Therapies products include Venous, Thrombus Management, as well as other core products. The Company's BioFlo products incorporate Endexo Technology into the manufacturing and design of its Vascular Access products. Its Oncology product offerings include its Microwave Ablation products, Radiofrequency Ablation (RFA) and its NanoKnife product lines. Through its subsidiary, Eximo Medical, Ltd., the Company operates 355 nanometers (nm) wavelength laser-technology platform.

Webull offers kinds of AngioDynamics, Inc. stock information, including NASDAQ:ANGO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANGO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ANGO stock methods without spending real money on the virtual paper trading platform.